PMID: 11324961Apr 28, 2001Paper

Feasibility of automatic marker detection with an a-Si flat-panel imager

Physics in Medicine and Biology
Aart J NederveenP Hofman

Abstract

Here we study automatic detection of implanted gold markers relative to the field boundary in portal images for on-line position verification. Portal images containing 1-2 MU were taken with an amorphous silicon flat-panel imager. The images were obtained with lateral field at 18 MV. Both the detection success rate and the localization accuracy of markers of 1.0 and 1.2 mm diameter were determined with the help of a marker detection method based on a marker extraction kernel. A method for determining a fiducial reference point related to the field boundary was developed. Detection success rates were 0.99, 0.90 and 0.95 for markers of 1.2 mm diameter and 5 mm length, 1.0 mm diameter and 5 mm length and 1.0 mm diameter and 10 mm length respectively. The localization accuracy appeared to be better than 0.3 mm. The reference point could be reproduced with an accuracy equal to 1 pixel (0.5 mm at isocentre) within one fraction. During the first few seconds of a treatment fraction the field edge was not stable, which appeared to be an effect of the motion of the radiation source. Thanks to the use an a-Si flat-panel imager, on-line position verification using implanted gold markers becomes clinically feasible. We can use a clinically ...Continue Reading

References

Jan 1, 1992·Medical Physics·A L BoyerJ Wong
Dec 1, 1991·Physics in Medicine and Biology·J BijholdH Meertens
Dec 1, 1995·International Journal of Radiation Oncology, Biology, Physics·J M BalterR K Ten Haken
Dec 1, 1995·International Journal of Radiation Oncology, Biology, Physics·S Vijayakumar, G T Chen
Jul 15, 1995·International Journal of Radiation Oncology, Biology, Physics·K P McGeeE E Martin
Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·J M BalterR K ten Haken
Oct 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M CrookB Esche
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·L E AntonukY el-Mohri
Oct 27, 1998·International Journal of Radiation Oncology, Biology, Physics·P BergströmA Widmark
Oct 27, 1998·International Journal of Radiation Oncology, Biology, Physics·L E AntonukJ Yorkston
Jun 15, 1999·Physics in Medicine and Biology·D MahJ A Rowlands
Sep 29, 1999·Medical Physics·Y El-MohriJ H Siewerdsen
Jul 13, 2000·International Journal of Radiation Oncology, Biology, Physics·A NederveenP Hofman

❮ Previous
Next ❯

Citations

Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Eleftheria AstreinidouJan J W Lagendijk
Nov 3, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A J NederveenJ J Lagendijk
Sep 21, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Bram van AsselenChris H J Terhaard
Mar 22, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Lennert S PloegerMarcel van Herk
Jul 17, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Homan DehnadJan J W Lagendijk
Jul 30, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Aart J NederveenJan J W Lagendijk
Sep 18, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Lennert S PloegerMarcel van Herk
May 15, 2002·International Journal of Radiation Oncology, Biology, Physics·Aart J NederveenJan J W Lagendijk
Mar 25, 2009·American Journal of Clinical Oncology·Carlos VargasJatinder Palta
Jul 11, 2003·Medical Physics·Jan-Jakob SonkeMarcel van Herk
Jan 18, 2005·Medical Physics·P J KeallR Mohan
Dec 13, 2012·Medical Physics·Balazs J NyiriLee H Gerig
Feb 7, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Paul M A van HaarenUulke A van der Heide
Feb 19, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Tara RosewallCharles Catton
Nov 21, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jan J W LagendijkUulke A van der Heide
May 22, 2007·International Journal of Radiation Oncology, Biology, Physics·Alexis N T J KotteUulke A van der Heide
Dec 5, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Uulke A van der HeideMarco van Vulpen
Apr 4, 2006·Hematology/oncology Clinics of North America·Joseph Y Ting, Todd J Scarbrough
Dec 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Emma J HarrisPhillip M Evans
Aug 30, 2008·IEEE Transactions on Medical Imaging·Zhiping MuGopinath Kuduvalli
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·Peter W M ChungCharles N Catton
Oct 7, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luc BeaulieuEric Vigneault
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Bram van AsselenChris H J Terhaard
Apr 20, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Daniel VetterliDaniel M Aebersold
May 9, 2003·The Urologic Clinics of North America·Alan PollackAlexandra L Hanlon
Apr 13, 2005·Otolaryngologic Clinics of North America·Meisong DingDavid Raben
Oct 9, 2004·Physics in Medicine and Biology·B W RaaymakersJ J W Lagendijk
Mar 22, 2014·Physics in Medicine and Biology·Hanlin WanParag Parikh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.